Anzeige
Mehr »
Donnerstag, 30.04.2026 - Börsentäglich über 12.000 News
Öl bricht über $108 und Wedgemount dreht die Produktion genau jetzt wieder an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16:42Halozyme Appoints Darren Snellgrove as Chief Financial Officer
15:42Achieve Transfers Cytisinicline Production to Adare Pharma Solutions
15:42Huahui Health, BeOne Medicines Partner to Advance Oncology Drug HH160
MiLaguna Diagnostics mRNA Gene Biomarker Test Gets FDA Breakthrough Device Status
MiConvergent Therapeutics Taps Andrew Davis as Chief Business and Strategy Officer
MiEcolab Opens Bioprocessing Applications Lab in Korea, Its First Bioprocessing Facility in Asia
MiFrontier Scientific Appoints Chief Commercial Officer
MiStrand Therapeutics Appoints Kunal Bhatia as Chief Financial Officer
MiEirgen Pharma Appoints Senior Leaders to New Executive Roles
MiSamsung Bioepis, ATLATL Partner on Open Innovation Program
MiChiesi Group Agrees to Acquire KalVista for $1.9B
MiContract Pharma Launches "Contract Pharma Stream' - 30+ Webinars, One Login, Anytime Access
DiIncyte Welcomes Suky Upadhyay as EVP, CFO
DiPrilenia Therapeutics Adds Lis Leiderman as CFO
DiCellares, Cabaletta Bio Ink 10-Year Commercial Supply Pact for Investigational CAR-T Therapy
DiShimadzu Introduces Nexera X4 Ultra High-Performance Liquid Chromatograph
DiGilead Completes $7.8 Billion Acquisition of Arcellx
DiImmunic Appoints Dr. Michael Panzara as Chief Medical Officer
DiThermo Fisher Scientific Opens Flagship U.S. Bioprocess Design Center in MA
DiTranspire Bio Opens Satellite R&D Facility in Shanghai
MoEvonik, Higuchi Announce New Joint Laboratory
MoAES Cleanroom Technology Taps John Groth as Chief Revenue Officer
MoPCI Pharma Services Invests in Infrastructure to Bolster Domestic Manufacturing Footprint
MoBD, Suttons Creek Partner to Support Pharma & Biotech Companies Developing Combination Products
MoLilly to Acquire Ajax Therapeutics Inc.